Literature DB >> 17981680

Splicing fidelity, enhancers, and disease.

Amanda S Solis1, Nikki Shariat, James G Patton.   

Abstract

Eukaryotic pre-mRNA splicing allows for a large, diverse proteome to be coded by a relatively small genome. Alternative splicing events are well regulated, but when mutations disrupt the splice sites or regulatory elements, disease can occur. Similarly, mutations can cause disease through aberrant transcript production. Enhancers, one of the splicing regulatory elements, are frequent targets of disease causing mutations. This review provides an overview of the splicing reaction and mechanisms of alternative splicing and provides examples of enhancer defects that cause disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17981680     DOI: 10.2741/2812

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  22 in total

1.  A syn-anti conformational difference allows SRSF2 to recognize guanines and cytosines equally well.

Authors:  Gerrit M Daubner; Antoine Cléry; Sandrine Jayne; James Stevenin; Frédéric H-T Allain
Journal:  EMBO J       Date:  2011-10-14       Impact factor: 11.598

2.  PSF suppresses tau exon 10 inclusion by interacting with a stem-loop structure downstream of exon 10.

Authors:  Payal Ray; Amar Kar; Kazuo Fushimi; Necat Havlioglu; Xiaoping Chen; Jane Y Wu
Journal:  J Mol Neurosci       Date:  2011-09-01       Impact factor: 3.444

Review 3.  Silencing human genetic diseases with oligonucleotide-based therapies.

Authors:  Tamara Martínez; Natalia Wright; Marta López-Fraga; Ana Isabel Jiménez; Covadonga Pañeda
Journal:  Hum Genet       Date:  2013-03-14       Impact factor: 4.132

4.  Adaptive Gene Loss? Tracing Back the Pseudogenization of the Rabbit CCL8 Chemokine.

Authors:  Wessel van der Loo; Maria João Magalhaes; Ana Lemos de Matos; Joana Abrantes; Fumio Yamada; Pedro J Esteves
Journal:  J Mol Evol       Date:  2016-06-15       Impact factor: 2.395

5.  Deep sequencing study of the MTHFR gene to identify variants associated with myelomeningocele.

Authors:  Chiamaka N Aneji; Hope Northrup; Kit Sing Au
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2012-01-12

6.  Cannabinoid receptor genotype moderation of the effects of childhood physical abuse on anhedonia and depression.

Authors:  Arpana Agrawal; Elliot C Nelson; Andrew K Littlefield; Kathleen K Bucholz; Louisa Degenhardt; Anjali K Henders; Pamela A F Madden; Nicholas G Martin; Grant W Montgomery; Michele L Pergadia; Kenneth J Sher; Andrew C Heath; Michael T Lynskey
Journal:  Arch Gen Psychiatry       Date:  2012-07

7.  Personalized exon skipping strategies to address clustered non-deletion dystrophin mutations.

Authors:  Sarah Forrest; Penny L Meloni; Francesco Muntoni; Jihee Kim; Sue Fletcher; Steve D Wilton
Journal:  Neuromuscul Disord       Date:  2010-12       Impact factor: 4.296

8.  Functional intronic polymorphisms: Buried treasure awaiting discovery within our genes.

Authors:  David N Cooper
Journal:  Hum Genomics       Date:  2010-06       Impact factor: 4.639

9.  Targeted genome-wide enrichment of functional regions.

Authors:  Periannan Senapathy; Ashwini Bhasi; Jeffrey Mattox; Perundurai S Dhandapany; Sakthivel Sadayappan
Journal:  PLoS One       Date:  2010-06-16       Impact factor: 3.240

10.  The intronic splicing code: multiple factors involved in ATM pseudoexon definition.

Authors:  Ashish Dhir; Emanuele Buratti; Maria A van Santen; Reinhard Lührmann; Francisco E Baralle
Journal:  EMBO J       Date:  2010-01-21       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.